Utilization of autologous superficial femoral vein graft in cases of infected prosthetic graft replacement and high infection-risk cases
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F19%3A00075949" target="_blank" >RIV/00159816:_____/19:00075949 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/19:00108562
Result on the web
<a href="https://www.ejves.com/action/showPdf?pii=S1078-5884%2819%2931671-5" target="_blank" >https://www.ejves.com/action/showPdf?pii=S1078-5884%2819%2931671-5</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejvs.2019.09.160" target="_blank" >10.1016/j.ejvs.2019.09.160</a>
Alternative languages
Result language
angličtina
Original language name
Utilization of autologous superficial femoral vein graft in cases of infected prosthetic graft replacement and high infection-risk cases
Original language description
Introduction: Aortic prosthetic graft infection is one of the most severe complications in vascular surgery. Good results are reported for the replacement using autologous superficial femoral vein (SFV) graft. This extensive procedure might be complicated by acute mesenteric ischemia (AMI). The aim of the study was to evaluate the safety of the procedure and options of early postoperative mesenteric ischemia detection. Methods: A retrospective review of 64 cases in which we have used autologous SFV graft was performed. The serum levels of biomarkers of AMI were assessed in comparison to 40 elective aortic surgery cases. Results: Average follow-up was 46.6 +/- 33.0 months, 30-day mortality was 6.3 %. The specificity of currently studied biomarkers of AMI (procalcitonin, ischemia modified albumin, I-FAPB2, and D-lactate) was low. Conclusions: Our results support the use of SFV graft for the treatment of aortic graft infection. Early postoperative detection of AMI remains challenging.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30200 - Clinical medicine
Result continuities
Project
<a href="/en/project/NV17-29701A" target="_blank" >NV17-29701A: Ischemia modified albumin and circulating microRNAs as a new technology for monitoring of tissue ischemia following abdominal aortic vascular surgery</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů